Asmanex (Mometasone furoate) for asthma

Overview
Asmanex is a prescription drug approved by the U.S. Food and Drug Administration (FDA) for maintenance treatment of asthma. Asmanex is indicated for use in people 5 years of age and older. Asmanex is not indicated for rescue usage during acute bronchospasms. Asmanex is also known by its drug name, Mometasone furoate.

Asmanex is a glucocorticoid steroid, a drug that suppresses the immune system. Asmanex is believed to work by reducing inflammation in the lungs, decreasing the risk for bronchospasm.

How do I take it?
Asmanex is inhaled orally once or twice a day. Asmanex should be taken at the same time or times each day.

Asmanex comes in the form of an aerosol or a powder, each of which requires a specific inhaler.

Side effects
Common side effects of Asmanex include cough, headache, pain in the sinuses or throat, fatigue, muscle and joint pain, and cold symptoms. Asmanex may suppress the immune system, raising the risk for infection.

Rare but serious side effects include anaphylaxis (a life-threatening allergic reaction), worsening infections, paradoxical bronchospasm (bronchospasm caused by taking medication), glaucoma and cataracts, and reduction in bone density.

For more details about this treatment, visit:
Asmanex – Merck
www.asmanex.com/